Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Resist diabetes: A randomized clinical trial for resistance training maintenance in adults with prediabetes.

Davy BM, Winett RA, Savla J, Marinik EL, Baugh ME, Flack KD, Halliday TM, Kelleher SA, Winett SG, Williams DM, Boshra S.

PLoS One. 2017 Feb 23;12(2):e0172610. doi: 10.1371/journal.pone.0172610. eCollection 2017.

2.

Activity and Sedentary Time 10 Years After a Successful Lifestyle Intervention: The Diabetes Prevention Program.

Rockette-Wagner B, Storti KL, Dabelea D, Edelstein S, Florez H, Franks PW, Montez MG, Pomeroy J, Kriska AM; Diabetes Prevention Program Research Group..

Am J Prev Med. 2017 Mar;52(3):292-299. doi: 10.1016/j.amepre.2016.10.007. Epub 2016 Nov 22.

PMID:
27887769
3.

Statistical power considerations in genotype-based recall randomized controlled trials.

Atabaki-Pasdar N, Ohlsson M, Shungin D, Kurbasic A, Ingelsson E, Pearson ER, Ali A, Franks PW.

Sci Rep. 2016 Nov 25;6:37307. doi: 10.1038/srep37307.

4.

Implementation of the YMCA Diabetes Prevention Program throughout an Integrated Health System: A Translational Study.

Adams R, Hebert CJ, Mcvey L, Williams R.

Perm J. 2016 Fall;20(4):82-86. doi: 10.7812/TPP/15-241.

5.

Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention.

O'Brien MJ, Moran MR, Tang JW, Vargas MC, Talen M, Zimmermann LJ, Ackermann RT, Kandula NR.

Diabetes Educ. 2016 Dec;42(6):667-677. Epub 2016 Sep 12.

6.

Replication of the Association of BDNF and MC4R Variants With Dietary Intake in the Diabetes Prevention Program.

McCaffery JM, Jablonski KA, Franks PW, Delahanty LM, Aroda V, Marrero D, Hamman RF, Horton ES, Dagogo-Jack S, Wylie-Rosett J, Barrett-Connor E, Kitabchi A, Knowler WC, Wing RR, Florez JC; Diabetes Prevention Program Research Group..

Psychosom Med. 2017 Feb/Mar;79(2):224-233. doi: 10.1097/PSY.0000000000000380.

PMID:
27551991
7.
8.

The PILI@Work Program: a translation of the diabetes prevention program to Native Hawaiian-serving worksites in Hawai'i.

Townsend CK, Miyamoto RE, Antonio M, Zhang G, Paloma D, Basques D, Braun KL, Kaholokula JK.

Transl Behav Med. 2016 Jun;6(2):190-201. doi: 10.1007/s13142-015-0383-3.

9.

Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.

Pradeepa R, Nazir A, Mohan V.

Heart Asia. 2012 Jan 1;4(1):69-76. doi: 10.1136/heartasia-2011-010081. eCollection 2012.

10.

A randomized controlled trial testing an Internet delivered cost-benefit approach to weight loss maintenance.

Leahey TM, Fava JL, Seiden A, Fernandes D, Doyle C, Kent K, La Rue M, Mitchell M, Wing RR.

Prev Med. 2016 Nov;92:51-57. doi: 10.1016/j.ypmed.2016.04.013. Epub 2016 Apr 17.

PMID:
27095323
11.

Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration.

Schaun MI, Eibel B, Kristocheck M, Sausen G, Machado L, Koche A, Markoski MM.

Stem Cells Int. 2016;2016:2171035. doi: 10.1155/2016/2171035. Epub 2016 Jan 5. Review.

12.

Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program.

Walford GA, Ma Y, Clish C, Florez JC, Wang TJ, Gerszten RE; Diabetes Prevention Program Research Group..

Diabetes. 2016 May;65(5):1424-33. doi: 10.2337/db15-1063. Epub 2016 Feb 9.

13.

What You Don't Know: Improving Family Health History Knowledge among Multigenerational Families of Mexican Origin.

Goergen AF, Ashida S, Skapinsky K, de Heer HD, Wilkinson AV, Koehly LM.

Public Health Genomics. 2016;19(2):93-101. doi: 10.1159/000443473. Epub 2016 Feb 9.

14.

NIH working group report-using genomic information to guide weight management: From universal to precision treatment.

Bray MS, Loos RJ, McCaffery JM, Ling C, Franks PW, Weinstock GM, Snyder MP, Vassy JL, Agurs-Collins T; Conference Working Group..

Obesity (Silver Spring). 2016 Jan;24(1):14-22. doi: 10.1002/oby.21381. Review. Erratum in: Obesity (Silver Spring). 2016 Mar;24(3):757.

15.

Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants.

Hivert MF, Christophi CA, Franks PW, Jablonski KA, Ehrmann DA, Kahn SE, Horton ES, Pollin TI, Mather KJ, Perreault L, Barrett-Connor E, Knowler WC, Florez JC; Diabetes Prevention Program Research Group..

Diabetes. 2016 Feb;65(2):520-6. doi: 10.2337/db15-0950. Epub 2015 Nov 2.

16.

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.

Diabetes Prevention Program Research Group..

Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. doi: 10.1016/S2213-8587(15)00291-0. Epub 2015 Sep 13.

17.

The National Diabetes Prevention Programme.

Barry E, Greenhalgh T.

Br J Gen Pract. 2015 Sep;65(638):450. doi: 10.3399/bjgp15X686389. No abstract available.

18.

Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort.

Mather KJ, Pan Q, Knowler WC, Funahashi T, Bray GA, Arakaki R, Falkner B, Sharma K, Goldstein BJ; DPP Research Group..

PLoS One. 2015 Aug 27;10(8):e0136853. doi: 10.1371/journal.pone.0136853. eCollection 2015.

19.

Smartphone applications to support weight loss: current perspectives.

Pellegrini CA, Pfammatter AF, Conroy DE, Spring B.

Adv Health Care Technol. 2015 Jul;1:13-22.

20.

Translation of the Diabetes Prevention Program for diabetes risk reduction in Chinese immigrants in New York City.

Yeh MC, Heo M, Suchday S, Wong A, Poon E, Liu G, Wylie-Rosett J.

Diabet Med. 2016 Apr;33(4):547-51. doi: 10.1111/dme.12848. Epub 2015 Aug 18.

Supplemental Content

Support Center